- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-1-mer
- Ligands
- 11 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 27 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.12: 2 residues within 4Å:- Chain A: N.280, N.282
Ligand excluded by PLIPNAG.13: 3 residues within 4Å:- Chain A: N.331, P.579, Q.580
Ligand excluded by PLIPNAG.14: 5 residues within 4Å:- Chain A: F.338, G.339, F.342, N.343, V.367
Ligand excluded by PLIPNAG.15: 1 residues within 4Å:- Chain A: N.603
Ligand excluded by PLIPNAG.16: 1 residues within 4Å:- Chain A: N.616
Ligand excluded by PLIPNAG.17: 1 residues within 4Å:- Chain A: N.657
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain A: N.709, G.1131
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain A: A.706, E.1072, N.1074
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain B: T.108, N.234
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain B: E.281, N.282
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain B: N.331, Q.580
Ligand excluded by PLIPNAG.24: 5 residues within 4Å:- Chain B: F.338, G.339, F.342, N.343, V.367
Ligand excluded by PLIPNAG.25: 1 residues within 4Å:- Chain B: N.603
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Chain B: N.616
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain B: H.655, N.657
Ligand excluded by PLIPNAG.28: 4 residues within 4Å:- Chain B: N.709, I.1130, G.1131
- Chain C: D.796
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain B: N.717, Q.1071
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain B: A.706, E.1072, N.1074
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain C: F.59, S.60, N.61
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain C: N.282
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain C: N.331, Q.580
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain C: N.616, Q.644
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain C: N.657
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain C: N.709, I.1130, G.1131
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain A: Q.895
- Chain C: A.706, E.1072, N.1074
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain C: N.1134
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dejnirattisai, W. et al., The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell (2021)
- Release Date
- 2021-03-03
- Peptides
- Spike glycoprotein: ABC
COVOX-150 Fab heavy chain: D
COVOX-150 Fab light chain: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HE
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-1-mer
- Ligands
- 11 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 27 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dejnirattisai, W. et al., The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell (2021)
- Release Date
- 2021-03-03
- Peptides
- Spike glycoprotein: ABC
COVOX-150 Fab heavy chain: D
COVOX-150 Fab light chain: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HE
L